India’s healthcare sector is set to receive a major boost with the government’s announcement of a new comprehensive scheme aimed at enhancing the medical devices industry, extending beyond the current Production Linked Incentive (PLI) framework.
The development follows the successful implementation of the PLI schemes and the recent approval of the Medical Devices policy. Dr. Arunish Chawla, Secretary of the Department of Pharmaceuticals under the ministry of chemicals and fertilizers stated, “The PLI schemes for medical devices have been effective, and we are now moving towards a post-PLI strategy”.
He highlighted that the new scheme is designed to support the industry and decrease India’s reliance on imports over the coming years. The proposed initiative will include five main components. Firstly, it aims to create Common Facilities for medical device clusters, providing shared infrastructure to enhance manufacturing capabilities.
Secondly, the scheme will focus on capacity building and skill development, ensuring a skilled workforce to support industry expansion. Thirdly, a Marginal Investment Scheme will be introduced to lower import dependence by encouraging domestic production of essential components and devices.
Fourthly, there will be increased support for clinical trials, acknowledging the vital role of research and development in the medical devices sector. Finally, a comprehensive promotion scheme for medical devices will be launched to boost the visibility and competitiveness of Indian-made devices in international markets.
Dr. Chawla also highlighted the need for more investment in clinical trials, urging the industry to allocate additional resources to this crucial area for product credibility and efficacy.
As reported by knnindia.co.in, Dr. Chawla noted that the government has partnered with relevant skill development councils to address this challenge.